 The purpose of this trial is to test the combination of Gleevec also known as imatinib mesylate and Taxotere also known as docetaxel in patients with incurable stomach cancer. This study is being performed to see if the combination of Gleevec and Taxotere is an effective treatment for incurable stomach cancer with minimal side effects. 